The Study of Personalized Health Check-up Programs and Standards for High-altitude Migrant Populations

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07018193

Enrollment

300

Registered

2025-06-12

Start date

2025-06-30

Completion date

2028-12-31

Last updated

2025-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High Altitude

Brief summary

By using wearable devices to monitor and record the physiological data changes and health outcomes (incidence and severity of high-altitude illnesses) of high-altitude migrants at different stages (pre-entry, acute/chronic high-altitude phases, and de-acclimatization phase), and referencing previous cohort studies on high-altitude populations, the study aims to provide a basis for developing personalized health assessment protocols for high-altitude migrants. The formulated assessment protocols and standards will then be validated.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Men and women aged ≥18; * Those living in plains and preparing to move to the plateau for a short-term or medium-term period; * Can understand the research requirements and be willing to sign a written informed consent form (ICF).

Exclusion criteria

* Past history of contraindicated plateau travel: such as advanced COPD (FEV₁\<30% of the expected value or requires continuous oxygen therapy), advanced cystic fibrosis (FEV₁\<30% of the expected value or requires continuous oxygen therapy), advanced restricted pulmonary disease (FEV₁\<50% of the expected value or requires continuous oxygen therapy), decompensated heart failure, high-risk pregnancy, myocardial infarction or stroke occurred within 90 days, poorly controlled epilepsy, pulmonary hypertension (PASP\>90mmHg), sickle cell anemia, unstable angina pectoris, high-risk cerebrovascular abnormalities that have not been treated, etc.

Design outcomes

Primary

Measure	Time frame	Description
Rates of high altitude sickness and related diseases.	through study completion, an average of 3 years	Early diagnosis rates of acute and chronic altitude sickness and related diseases induced or aggravated by the plateau population in migrant plateau populations.

Contacts

Primary ContactYuan Wang, MD

wilma0106@163.com+86-13581567815

Outcome results